It’s a city where students have marched in the streets to save two Picasso paintings from sale. It boasts the world’s oldest ...

Swiss pharmaceutical giant Novartis is poised to expand its profile in the San Diego area, announcing plans to acquire Regulus Therapeutics, a local company on the cusp of bringing a potential ...

The Eurovision Song Contest 2025 invites everyone to Feel the Beat, an inclusive disco night designed for people with and ...

Despite these benefits, biosimilar medicines remain under-recognised and underused in many markets. Real-world uptake often ...

Bitpanda partners with FC Basel as its main sponsor for the 2025/26 season, marking its first kit sponsorship and focus on ...

BASEL, Switzerland I April 29, 2025 I Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, announced today that it has signed ...

Swiss chemicals giant Clariant does not intend to increase US investments, unlike pharma firms Roche and Novartis.

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE <li /> Q1 2025 net sal ...

Swiss pharmaceutical giant Novartis has continued the strong pace of growth of recent quarters in the first three months of ...

During an earnings call, the firm reported strong sales for Pluvicto and other precision medicines and elaborated on its US manufacturing plans.

Granite Bio AG, a clinical-stage immunology company based in Basel, Switzerland, and San Francisco, California, emerged from ...

Novartis raised its 2025 outlook after its core operating profit rose 23% on year, boosted by strong demand for its key drugs ...